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A threefold increase for  testicular  carcinoma has been repor ted in male dizygotic tw ins. In this
comment we suggest the hypothesis that over-exposure to endogenously hypersecreted Fol l icle
Stimulating Hormone (FSH) may under l ie the pathogenesis. This is suppor ted by several  findings.
1) FSH hypersecretion in mothers of dizygotic tw ins is most l ikely an autosomal  trai t impl icating
the possibi l i ty of male offspr ing wi th the same hormone character istic. 2) In testicular  carcinoma
higher  levels of cycl in D2 are found. This is an FSH dependent stimulatory regulator  of mi tosis. 3)
There is a marked simi lar i ty between geographical  distr ibution in occurence of dizygotic tw inning
and testicular  carcinoma. 4) Men undergoing surgery for  testicular  carcinoma have higher  FSH
concentrations and males wi th Down syndrome have higher  FSH levels and are more at r isk  to
develop testicular  carcinoma. We suggest to study FSH secretion in males of fami l ial  dizygotic
twins and fur thermore the r isk  of developing testicular  carcinoma in males wi th elevated FSH.
These men wi th one testicle and/or  wi th dysfunctioning Ser tol i /Leydig cel ls.
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Males of dizygotic tw ins are up to three times more
at risk for testicular cancer (in particular seminomas)
(Odd ratio: 2.8 wi th 95% confidence intervals of
1.1–7.0) than males of monozygotic tw ins. This was
one important finding in a study conducted by
Swerdlow et al publ ished in the Lancet of 13 Decem-
ber 1997.
1
They identified twins wi th testicular
cancer diagnosed in England and Wales during
1971–1989. In addi tion to the risk associated wi th
being a dizygotic tw in, men wi th a twin brother wi th
testicular carcinoma have a greatly increased risk of
developing testicular cancer themselves – 75-fold in
monozygotic and 38-fold in dizygotic tw ins. The
same study also reports a 35-fold increase in risk of
breast cancer in monozygotic tw in sisters of young
women wi th breast cancer. Females of dizygotic
twins have no increased risk of breast cancer
compared to monozygotic tw ins (Odd Ratio of 1.1
wi th 95% confidence l imi ts of 0.8–1.4). Young
dizygotic sisters (up to 35 years old) of probands
wi th breast cancer had also no increase in risk. In
this si tuation, the risk increased significantly about
5-fold when over 35 years of age.
The study is at least doubly significant: i t points to
a mechanism for testicular cancer that is associated
wi th dizygotic tw inning and i t provides strong
support for genetic mechanisms involved in the
aetiology of testis carcinoma. This is in agreement
wi th an observed 12-fold increased risk of testis
carcinoma in non-twin brothers of affected males.
2
The higher incidence in dizygotic versus mono-
zygotic tw ins as reported by Swerdlow and col -
leagues points to a risk factor that is unique to
dizygotic tw ins. In the original  publ ication, an
envi ronmental  rather than a genetic hypothesis is
put forward. Nowadays, overexposure to oestrogenic
substances ei ther from the mother or the envi ron-
ment are often mentioned when i t comes to male
reproductive organ dysfunction. The authors suggest
that the increased risk in dizygotic tw ins is related to
intra-uterine exposure to raised oestrogen concentra-
tions. However, there is currently no good evidence
for such oestrogenic over-exposure during the preg-
nancy of a dizygotic tw in compared to monozygotic
twin pregnancies. An al ternative would be that the
findings point to yet another heredi tary endocrine
mechanism.
A number of mothers of fami l ial  dizygotic tw ins
show hypersecretion by the pi tui tary of fol l icle
stimulating hormone (FSH).
3,4
This causes mul tiple
fol l icle growth, higher levels of oestrogens and
mul tiple ovulation.
3,5,6
There is no evidence that the
trai t of having dizygotic tw ins is inheri ted in an
x-l inked manner.
7
This means that male offspring
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(including twins) of these mothers may carry the
involved gene(s). At the moment most evidence
points towards the hypothalamus or the pi tui tary as
the primary si te of di fference in regulation of FSH
secretion between mothers of fami l ial  dizygotic
twins and controls and that there is no di fference in
mode of hormonal  feedback by the gonads.
3
This
may suggest that male carriers of the gene(s) also
hypersecrete FSH.
In males, over-exposure to FSH from puberty
onwards is a good candidate for involvement in the
aetiology of testis carcinoma. In the first place,
testicular carcinoma may be associated wi th
increased FSH action mediated by cycl in D2.
8
Cycl ins are proteins that are of importance in the
regulation of the mi totic cel l  division and cycl in D2
messenger RNA is found to be expressed in high
amounts in testicular and ovarian tumours. Men
undergoing surgery for testicular carcinoma and
particularly those that developed a second contra-
lateral  germ cel l  tumour had higher ci rculating
concentrations of FSH.
9
Also, there seems to be an
increased risk in testicular carcinoma in men wi th
Down syndrome which is a condi tion that is also
associated wi th increased levels of serum FSH.
9
Secondly, there is remarkable simi lari ty in geo-
graphic distribution of dizygotic tw inning and larger
testicular volume and the incidence of testis
tumours.
10,11
In Scandinavian populations both the
incidence of DZ twinning and of testicular cancer are
among the highest in the world. Contrastingly, the
incidence of both condi tions is lowest in East Asian
populations. Moreover, Northern Europeans have
larger testes than East Asians.
10
A uni fying explana-
tion for this coincidence would be that genetic
compounds leading to higher FSH levels are more
common in North European than in Far East
regions.
To investigate these suggested mechanisms we
propose that several  studies should be carried out.
No data are currently avai lable on the secretion of
gonadotropins in fami l ial  male dizygotic tw ins. We
need to demonstrate that FSH levels are indeed
higher in male dizygotic tw ins as wel l  as in males
whose mothers had dizygotic tw ins. Obviously i t is
important to evaluate the incidence of testicular
carcinoma in males who have prolonged periods of
elevated serum FSH levels. This is the case in males
wi th only one testicle and in many males wi th
dysfunctioning Sertol i /Leydig cel ls resul ting in
reduced hormonal  negative feedback towards the
pi tui tary gland.
Hopeful ly, in the near future, the gene(s) that
underl ie al tered regulation of FSH secretion in
twinning wi l l  be identified. These wi l l  then serve as
prime candidate genes in sib-pai r studies of tes-
ticular carcinoma.
The findings by Swerdlow and col leagues empha-
sise the cl inical  importance of research into the
etiology of dizygotic tw inning and demonstrate the
great value of epidemiologic studies wi th twins in
cancer research. In particular, the 35-fold increased
risk in monozygotic tw in sisters of patients wi th
breast cancer and the 38 to 75-fold increase in twin
brothers of patients wi th testicular cancer meri t
immediate cl inical  attention.
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